Assessment of Clopidogrel plus Eptifibatide versus Ticagrelor
Not Applicable
- Conditions
- Acute myocardial infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- IRCT20200318046810N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 116
Inclusion Criteria
Patients with acute chest pain and ST elevation in electrocardiogram
Exclusion Criteria
Patients with recent history of using clopidogrel
Patients presenting with cardiogenic shock
Patients with advanced valvular heart disease
Patients who are candidate for urgent cardiac surgery
Patients presenting more 12 hours after onset of symptoms
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method o reflow phenomenon. Timepoint: After implantation of stent. Method of measurement: Coronary Angiography views.;ST resolution in EKG. Timepoint: 90 minutes after angiography. Method of measurement: more than 50%decreasing of ST segment.
- Secondary Outcome Measures
Name Time Method Major and minor bleeding. Timepoint: after pci. Method of measurement: decreasing of Hb and intracranial bleedind and deadly bleeding.;MACCE(mortality and CVA and reMI). Timepoint: after angiography. Method of measurement: the numbering of reMI and CVA and mortality.